title: [Pneumothorax during nasal-CPAP: a predictable complication?].
abstract: OBJECTIVE
  Pneumothorax (PNX) is a relatively common complication of nasal-CPAP (N-CPAP). Aim of the study was to identify prognostic factors of its onset.
  
  
  METHODS
  Seventy-seven newborns, admitted from January to December 2002 to the Neonatal Intensive Care Unit of Brescia, who were treated with N-CPAP with Infant Flow System as first intention, were included. Gestational age and birth weight were (mean +/- SD) 33.7 +/- 3.02 weeks and 2.047 +/- 684 grams, respectively. Infants were put on N-CPAP at 2.7 +/- 4.1 hours of life. The duration of treatment was 27.7 +/- 27.7 hours.
  
  
  RESULTS
  Fifty-one neonates improved and N-CPAP was discontinued, 26 worsened and required intubation and mechanical ventilation. Eight of them developed PNX (10,3%). No significant differences were found among the three groups (improved, worsened without PNX and worsened with PNX) concerning mode of delivery, gestational age, birth weight and blood gases. The patients with PNX needed a FiO2 28% higher than the initial value after 12 hours of treatment, and 46% higher at 24 hours (p = 0,017). At diagnosis, FiO2 was 53,5% higher than the initial value (p = 0,005).
  
  
  CONCLUSIONS
  A 40% increase of FiO2, during the first 24 hours of N-CPAP may represent an useful marker to identify the infants at high risk of developing a pneumothorax.
authors.affiliation: Divisione di Neonatologia e Terapia Intensiva Neonatale, Spedali Civili, Brescia. claudio.migliori@tin.it
authors.forename: C
authors.initials: C
authors.lastname: Migliori
authors.forename: A
authors.initials: A
authors.lastname: Campana
authors.forename: D
authors.initials: D
authors.lastname: Cattarelli
authors.forename: F
authors.initials: F
authors.lastname: Pontiggia
authors.forename: G
authors.initials: G
authors.lastname: Chirico
mesh_terms: D045422:Continuous Positive Airway Pressure / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D011030:Pneumothorax / Q000209:etiology* / Q000517:prevention & control